Genmab | GEN - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Almirall EUR 2.41B 345.65M 2026-05
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
argenx SE USD 39.98B 4.4B 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Demant DKK 52.27B 6.26B 2026-05
Exelixis USD 14.34B 3.44B 2026-05
Fresenius Medical Care EUR 10.89B 429.56M 2026-05
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GN Store Nord DKK 14.08B 1.14B 2026-05
GRIFOLS EUR 3.69B 1.9B 2026-05
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Insmed USD 15.56B 19.73B 2026-05
Lakefront Biotherapeutics EUR 1.58B 147.61M 2026-05
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 51.28B 4.5B 2026-05
Novartis USD 232.75B 75B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12